Read + Share
Fonseca Chebli JM, Akkari Evangelista RK, Chebli LA. Persistent constitutional symptoms and cholestasis during anti-TNF therapy as a
harbinger of a surprising condition. Gastroenterology 2023 Jul 23:S0016-5085(23)04787.
PMID: 37490972
|
 |
|
Fonseca Chebli JM, Akkari Evangelista RK, Chebli LA. Persistent constitutional symptoms and cholestasis during anti-TNF therapy as a
harbinger of a surprising condition. Gastroenterology 2023 Jul 23:S0016-5085(23)04787.
PMID: 37490972
|
|
|
|